Symbols / GOVX $1.71 -0.58%
GOVX Chart
About
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. The company is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. It also developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 3.80M |
| Enterprise Value | -2.98M | Income | -25.31M | Sales | 3.35M |
| Book/sh | 4.13 | Cash/sh | 4.22 | Dividend Yield | — |
| Payout | 0.00% | Employees | 17 | IPO | — |
| P/E | — | Forward P/E | -1.99 | PEG | — |
| P/S | 1.13 | P/B | 0.41 | P/C | — |
| EV/EBITDA | 0.12 | EV/Sales | -0.89 | Quick Ratio | 2.75 |
| Current Ratio | 3.57 | Debt/Eq | — | LT Debt/Eq | — |
| EPS (ttm) | -31.75 | EPS next Y | -0.86 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2026-03-19 | ROA | -178.93% |
| ROE | -3.77% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | -7.62% | Profit Margin | 0.00% | Shs Outstand | 2.22M |
| Shs Float | 1.19M | Short Float | 9.49% | Short Ratio | 1.47 |
| Short Interest | — | 52W High | 37.75 | 52W Low | 1.26 |
| Beta | 3.88 | Avg Volume | 176.13K | Volume | 35.33K |
| Target Price | $270.83 | Recom | None | Prev Close | $1.72 |
| Price | $1.71 | Change | -0.58% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$270.83
Mean price target
2. Current target
$1.71
Latest analyst target
3. DCF / Fair value
$-121.12
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.71
Low
$212.50
High
$350.00
Mean
$270.83
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-02-19 | down | D. Boral Capital | Buy → Hold | — |
| 2026-01-21 | main | D. Boral Capital | Buy → Buy | $6 |
| 2025-11-19 | main | D. Boral Capital | Buy → Buy | $6 |
| 2025-09-26 | main | D. Boral Capital | Buy → Buy | $9 |
| 2025-08-07 | main | D. Boral Capital | Buy → Buy | $9 |
| 2025-07-29 | main | D. Boral Capital | Buy → Buy | $9 |
| 2025-07-17 | main | D. Boral Capital | Buy → Buy | $9 |
| 2025-06-16 | main | D. Boral Capital | Buy → Buy | $9 |
| 2025-05-02 | main | D. Boral Capital | Buy → Buy | $9 |
| 2025-04-16 | reit | HC Wainwright & Co. | Buy → Buy | $8 |
| 2025-04-15 | main | D. Boral Capital | Buy → Buy | $14 |
| 2025-04-10 | main | D. Boral Capital | Buy → Buy | $18 |
| 2025-03-28 | main | D. Boral Capital | Buy → Buy | $18 |
| 2025-02-27 | main | D. Boral Capital | Buy → Buy | $18 |
| 2025-01-31 | main | D. Boral Capital | Buy → Buy | $18 |
| 2025-01-16 | main | D. Boral Capital | Buy → Buy | $18 |
| 2024-12-18 | main | D. Boral Capital | Buy → Buy | $18 |
| 2024-11-20 | reit | HC Wainwright & Co. | Buy → Buy | $8 |
| 2024-11-19 | main | D. Boral Capital | Buy → Buy | $18 |
| 2024-11-15 | reit | HC Wainwright & Co. | Buy → Buy | $8 |
- GOVX Technical Analysis | Trend, Signals & Chart Patterns | GEOVAX LABS INC (NASDAQ:GOVX) - ChartMill Wed, 11 Mar 2026 07
- How The Story On GeoVax Labs (GOVX) Is Shifting Toward Execution Risk And Funding Constraints - Yahoo Finance Wed, 11 Mar 2026 17
- Geovax Labs (GOVX) Receives "Buy" Rating Again from D. Boral Cap - GuruFocus Wed, 21 Jan 2026 08
- $GOVX stock is up 15% today. Here's what we see in our data. - Nasdaq Mon, 16 Jun 2025 07
- $GOVX stock is down 25% today. Here's what we see in our data. - Quiver Quantitative ue, 30 Sep 2025 07
- GeoVax Announces 1-for-25 Reverse Stock Split to Regain Compliance With Nasdaq Minimum Bid Requirement - TradingView hu, 08 Jan 2026 08
- GeoVax Labs (Nasdaq: GOVX) raises about $1M in direct stock and warrant deal - Stock Titan ue, 17 Feb 2026 08
- Would You Still Hold Geovax Labs Stock If It Fell Another 30%? - Trefis Sat, 20 Dec 2025 08
- GeoVax Labs Executes Reverse Stock Split and Charter Amendments - TipRanks Mon, 12 Jan 2026 08
- GeoVax Labs (GOVX) Upgraded to Buy: What Does It Mean for the Stock? - Yahoo Finance Wed, 20 Aug 2025 07
- Earnings call transcript: GeoVax Q3 2025 shows revenue decline, stock dips - Investing.com hu, 13 Nov 2025 08
- D. Boral Capital Maintains GeoVax Labs (GOVX) Buy Recommendation - Nasdaq Fri, 26 Sep 2025 07
- GeoVax Labs (GOVX) Issues New Stock Units with Warrants | GOVX S - GuruFocus Mon, 16 Jun 2025 07
- GeoVax Labs Announces Public Equity Offering for Liquidity - TipRanks Mon, 22 Dec 2025 08
- Earnings call transcript: GeoVax Labs Q2 2025 sees revenue surge, stock dips - Investing.com Mon, 28 Jul 2025 07
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 10000 | 5498 | — | Purchase at price 0.55 per share. | SPENCER JOHN N JR | Director | — | 2025-10-17 00:00:00 | D |
| 1 | 1107 | 742 | — | Purchase at price 0.67 per share. | MCKEE KELLY T JR. | Officer | — | 2025-08-07 00:00:00 | D |
| 2 | 6000 | 5940 | — | Purchase at price 0.99 per share. | SHARKEY JOHN W PH.D. | Officer | — | 2025-04-10 00:00:00 | D |
| 3 | 10000 | 10800 | — | Purchase at price 1.08 per share. | DODD DAVID A | Chief Executive Officer | — | 2025-04-01 00:00:00 | D |
| 4 | 6800 | 7343 | — | Purchase at price 1.08 per share. | REYNOLDS MARK W | Chief Financial Officer | — | 2025-03-31 00:00:00 | D |
| 5 | 8000 | 15600 | — | Purchase at price 1.95 per share. | DODD DAVID A | Chief Executive Officer | — | 2024-08-09 00:00:00 | D |
| 6 | 8729 | 19781 | — | Purchase at price 2.15 - 2.27 per share. | DODD DAVID A | Chief Executive Officer | — | 2024-02-22 00:00:00 | D |
| 7 | 2000 | 5540 | — | Purchase at price 2.77 per share. | REYNOLDS MARK W | Chief Financial Officer | — | 2024-02-07 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 0.00 | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.00 | 0.00 | 0.00 | 0.00 |
| NormalizedEBITDA | -24.88M | -25.89M | -13.97M | -18.70M |
| TotalUnusualItems | 0.00 | 172.06K | ||
| TotalUnusualItemsExcludingGoodwill | 0.00 | 172.06K | ||
| NetIncomeFromContinuingOperationNetMinorityInterest | -24.99M | -25.97M | -14.02M | -18.57M |
| ReconciledDepreciation | 95.37K | 74.17K | 56.28K | 38.52K |
| EBITDA | -24.88M | -25.89M | -13.97M | -18.53M |
| EBIT | -24.97M | -25.97M | -14.03M | -18.57M |
| NetInterestIncome | 151.98K | 776.18K | 7.44K | 3.45K |
| InterestExpense | 21.38K | 0.00 | 0.00 | 1.29K |
| InterestIncome | 173.36K | 776.18K | 7.44K | 4.74K |
| NormalizedIncome | -24.99M | -25.97M | -14.02M | -18.74M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -24.99M | -25.97M | -14.02M | -18.57M |
| TotalExpenses | 29.10M | 26.74M | 14.11M | 19.13M |
| TotalOperatingIncomeAsReported | -25.14M | -26.74M | -14.03M | -18.75M |
| DilutedAverageShares | 207.48K | 72.69K | 45.26K | 16.27K |
| BasicAverageShares | 207.48K | 72.69K | 45.26K | 16.27K |
| DilutedEPS | -120.50 | -357.25 | -311.25 | -1.14K |
| BasicEPS | -120.50 | -357.25 | -311.25 | -1.14K |
| DilutedNIAvailtoComStockholders | -24.99M | -25.97M | -14.02M | -18.57M |
| NetIncomeCommonStockholders | -24.99M | -25.97M | -14.02M | -18.57M |
| NetIncome | -24.99M | -25.97M | -14.02M | -18.57M |
| NetIncomeIncludingNoncontrollingInterests | -24.99M | -25.97M | -14.02M | -18.57M |
| NetIncomeContinuousOperations | -24.99M | -25.97M | -14.02M | -18.57M |
| PretaxIncome | -24.99M | -25.97M | -14.02M | -18.57M |
| OtherIncomeExpense | 172.06K | |||
| SpecialIncomeCharges | 0.00 | 172.06K | ||
| OtherSpecialCharges | -172.06K | |||
| NetNonOperatingInterestIncomeExpense | 151.98K | 776.18K | 7.44K | 3.45K |
| InterestExpenseNonOperating | 21.38K | 0.00 | 0.00 | 1.29K |
| InterestIncomeNonOperating | 173.36K | 776.18K | 7.44K | 4.74K |
| OperatingIncome | -25.14M | -26.74M | -14.03M | -18.75M |
| OperatingExpense | 29.10M | 26.74M | 14.11M | 19.13M |
| ResearchAndDevelopment | 23.71M | 20.72M | 9.12M | 15.55M |
| SellingGeneralAndAdministration | 5.39M | 6.02M | 4.99M | 3.58M |
| GeneralAndAdministrativeExpense | 5.39M | 6.02M | 4.99M | 3.58M |
| OtherGandA | 5.39M | 6.02M | 4.99M | 3.58M |
| TotalRevenue | 3.95M | 0.00 | 81.53K | 385.50K |
| OperatingRevenue | 3.95M | 0.00 | 81.53K | 385.50K |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 421.48K | 79.09K | 70.23K | 17.02K |
| ShareIssued | 421.48K | 79.09K | 70.23K | 17.02K |
| TangibleBookValue | 4.99M | 5.69M | 26.60M | 4.36M |
| InvestedCapital | 5.05M | 5.76M | 26.60M | 4.36M |
| WorkingCapital | 4.83M | 4.37M | 24.19M | 6.19M |
| NetTangibleAssets | 4.99M | 5.69M | 26.60M | 4.36M |
| CommonStockEquity | 5.05M | 5.76M | 26.60M | 4.36M |
| TotalCapitalization | 5.05M | 5.76M | 26.60M | 4.36M |
| TotalEquityGrossMinorityInterest | 5.05M | 5.76M | 26.60M | 4.36M |
| StockholdersEquity | 5.05M | 5.76M | 26.60M | 4.36M |
| RetainedEarnings | -129.36M | -104.36M | -78.40M | -64.38M |
| AdditionalPaidInCapital | 134.39M | 110.13M | 105.00M | 68.73M |
| CapitalStock | 10.54K | 1.98K | 1.76K | 6.38K |
| CommonStock | 10.54K | 1.98K | 1.76K | 6.38K |
| PreferredStock | 0.00 | |||
| TotalLiabilitiesNetMinorityInterest | 3.11M | 3.52M | 4.75M | 7.44M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 0.00 | 0.00 | 0.00 | 2.00M |
| OtherNonCurrentLiabilities | 2.00M | |||
| NonCurrentAccruedExpenses | 2.00M | |||
| CurrentLiabilities | 3.11M | 3.52M | 4.75M | 5.44M |
| PayablesAndAccruedExpenses | 3.11M | 3.52M | 4.75M | 5.44M |
| CurrentAccruedExpenses | 1.26M | 716.93K | 3.00M | 3.38M |
| Payables | 1.85M | 2.80M | 1.75M | 2.06M |
| AccountsPayable | 1.85M | 2.80M | 1.75M | 2.06M |
| TotalAssets | 8.16M | 9.28M | 31.35M | 11.80M |
| TotalNonCurrentAssets | 220.98K | 1.40M | 2.41M | 167.95K |
| OtherNonCurrentAssets | 1.19M | 2.17M | 11.01K | |
| NonCurrentPrepaidAssets | 11.01K | 1.12M | 2.17M | 11.01K |
| GoodwillAndOtherIntangibleAssets | 60.00K | 70.00K | 80.00K | 0.00 |
| OtherIntangibleAssets | 60.00K | 70.00K | 80.00K | |
| NetPPE | 149.97K | 209.69K | 234.91K | 156.94K |
| AccumulatedDepreciation | -761.04K | -680.67K | -606.50K | -550.22K |
| GrossPPE | 911.02K | 890.36K | 841.42K | 707.16K |
| Leases | 115.61K | 115.61K | 115.61K | 115.61K |
| MachineryFurnitureEquipment | 795.41K | 774.76K | 725.81K | 591.55K |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 7.93M | 7.89M | 28.94M | 11.63M |
| PrepaidAssets | 1.77M | 1.43M | 1.33M | 156.24K |
| Receivables | 659.41K | 0.00 | 0.00 | 49.01K |
| OtherReceivables | 659.41K | 49.01K | ||
| CashCashEquivalentsAndShortTermInvestments | 5.51M | 6.45M | 27.61M | 11.42M |
| CashAndCashEquivalents | 5.51M | 6.45M | 27.61M | 11.42M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -24.70M | -25.22M | -19.16M | -11.24M |
| RepurchaseOfCapitalStock | 0.00 | -1.00K | ||
| RepaymentOfDebt | -150.00K | 0.00 | 0.00 | -27.86K |
| IssuanceOfDebt | 135.00K | 0.00 | 0.00 | |
| IssuanceOfCapitalStock | 21.40M | 0.00 | 27.73M | 9.41M |
| CapitalExpenditure | -20.65K | -48.95K | -134.26K | -47.72K |
| EndCashPosition | 5.51M | 6.45M | 27.61M | 11.42M |
| BeginningCashPosition | 6.45M | 27.61M | 11.42M | 9.88M |
| ChangesInCash | -945.65K | -21.16M | 16.19M | 1.54M |
| FinancingCashFlow | 23.75M | 4.06M | 35.35M | 12.78M |
| CashFlowFromContinuingFinancingActivities | 23.75M | 4.06M | 35.35M | 12.78M |
| ProceedsFromStockOptionExercised | 2.37M | 4.06M | 7.63M | 3.40M |
| NetPreferredStockIssuance | 0.00 | -1.00K | ||
| PreferredStockPayments | 0.00 | -1.00K | ||
| PreferredStockIssuance | 0.00 | |||
| NetCommonStockIssuance | 21.40M | 0.00 | 27.73M | 9.41M |
| CommonStockIssuance | 21.40M | 0.00 | 27.73M | 9.41M |
| NetIssuancePaymentsOfDebt | -15.00K | 0.00 | 0.00 | -27.86K |
| NetShortTermDebtIssuance | -15.00K | 0.00 | 0.00 | -27.86K |
| ShortTermDebtPayments | -150.00K | 0.00 | 0.00 | -27.86K |
| ShortTermDebtIssuance | 135.00K | 0.00 | 0.00 | |
| NetLongTermDebtIssuance | 0.00 | 0.00 | ||
| LongTermDebtPayments | 0.00 | -27.86K | ||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -20.65K | -48.95K | -134.26K | -47.72K |
| CashFlowFromContinuingInvestingActivities | -20.65K | -48.95K | -134.26K | -47.72K |
| NetPPEPurchaseAndSale | -20.65K | -48.95K | -134.26K | -47.72K |
| PurchaseOfPPE | -20.65K | -48.95K | -134.26K | -47.72K |
| OperatingCashFlow | -24.68M | -25.17M | -19.03M | -11.20M |
| CashFlowFromContinuingOperatingActivities | -24.68M | -25.17M | -19.03M | -11.20M |
| ChangeInWorkingCapital | -307.23K | -356.00K | -5.97M | 6.93M |
| ChangeInOtherWorkingCapital | -2.16M | |||
| ChangeInOtherCurrentAssets | 1.12M | 986.50K | -2.16M | |
| ChangeInPayablesAndAccruedExpense | -412.55K | -1.23M | -2.69M | 6.81M |
| ChangeInPrepaidAssets | -352.05K | -114.49K | -1.17M | -16.27K |
| ChangeInReceivables | -659.41K | 0.00 | 49.01K | 133.66K |
| StockBasedCompensation | 528.64K | 1.07M | 902.07K | 369.99K |
| DepreciationAmortizationDepletion | 95.37K | 74.17K | 56.28K | 38.52K |
| DepreciationAndAmortization | 95.37K | 74.17K | 56.28K | 38.52K |
| Depreciation | 74.17K | 56.28K | ||
| OperatingGainsLosses | 37.77K | |||
| GainLossOnInvestmentSecurities | 209.82K | |||
| NetIncomeFromContinuingOperations | -24.99M | -25.97M | -14.02M | -18.57M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for GOVX
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|